Company Filing History:
Years Active: 2025
Title: Innovations of Yuanjie Wei in Cancer Research
Introduction
Yuanjie Wei is a notable inventor based in Suzhou, China. He has made significant contributions to the field of cancer research through his innovative work on human keratinocytes. His research focuses on understanding the carcinogenic effects of arsenic metabolites, which has important implications for public health.
Latest Patents
Yuanjie Wei holds a patent titled "Dimethylarsinous acid-induced malignantly transformed cell line of human keratinocytes and use thereof." This invention relates to the establishment of a model that helps in identifying the carcinogenicity of arsenic methylated metabolites. The patent describes a method where human keratinocytes are persistently exposed to low doses of dimethylarsinous acid, leading to the creation of a malignantly transformed cell model. This model is crucial for studying the carcinogenic mechanisms associated with arsenic exposure.
Career Highlights
Yuanjie Wei is affiliated with Soochow University, where he conducts his research. His work has garnered attention for its innovative approach to understanding cancer mechanisms. With a focus on the effects of inorganic arsenic metabolites, Wei's research contributes to the broader field of toxicology and cancer biology.
Collaborations
Yuanjie Wei collaborates with colleagues such as Yan An and Rui Yan. These partnerships enhance the research efforts and contribute to the development of new insights in cancer research.
Conclusion
Yuanjie Wei's innovative work in establishing a malignantly transformed cell line of human keratinocytes represents a significant advancement in cancer research. His contributions provide valuable insights into the carcinogenic effects of arsenic, paving the way for future studies in this critical area.